Targeted protein degradation as a powerful research tool in basic biology and drug target discovery

被引:0
作者
Tao Wu
Hojong Yoon
Yuan Xiong
Sarah E. Dixon-Clarke
Radosław P. Nowak
Eric S. Fischer
机构
[1] Dana Farber Cancer Institute,Department of Cancer Biology
[2] Harvard Medical School,Department of Biological Chemistry and Molecular Pharmacology
来源
Nature Structural & Molecular Biology | 2020年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Controlled perturbation of protein activity is essential to study protein function in cells and living organisms. Small molecules that hijack the cellular protein ubiquitination machinery to selectively degrade proteins of interest, so-called degraders, have recently emerged as alternatives to selective chemical inhibitors, both as therapeutic modalities and as powerful research tools. These systems offer unprecedented temporal and spatial control over protein function. Here, we review recent developments in this field, with a particular focus on the use of degraders as research tools to interrogate complex biological problems.
引用
收藏
页码:605 / 614
页数:9
相关论文
共 50 条
[41]   Systems biology visualization tools for drug target discovery [J].
Huan, Tianxiao ;
Wu, Xiaogang ;
Chen, Jake Y. .
EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (05) :425-439
[42]   Azoacetylene Electrophiles for Proteome-wide Ligand and Target Discovery: Supporting Targeted Protein Degradation [J].
Du, Jiayi ;
Li, Shengrong ;
Xu, Fang ;
Lin, Zehong ;
Hong, Tongyi ;
Li, Yifang ;
Deng, Zeyi ;
Tan, Yi ;
Li, Zhengqiu .
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (13) :13516-13531
[43]   Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation [J].
Gross, Patrick H. ;
Sheets, Katie J. ;
Warren, Noel A. ;
Ghosh, Saptarshi ;
Varghese, Rebekah E. ;
Wass, Katherine E. ;
Kadimisetty, Karteek .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 628 :68-75
[44]   The Use of Structural Biology in Janus Kinase Targeted Drug Discovery [J].
Alicea-Velazquez, Nilda L. ;
Boggon, Titus J. .
CURRENT DRUG TARGETS, 2011, 12 (04) :546-555
[45]   Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond [J].
Serafim, Ricardo A. M. ;
Gehringer, Matthias ;
Borsari, Chiara .
PHARMACEUTICALS, 2024, 17 (02)
[46]   Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery [J].
Kotadiya, Dushyant D. ;
Patel, Piyushkumar ;
Patel, Hitesh D. .
CURRENT DRUG DELIVERY, 2023, 21 (03) :368-388
[47]   Development of synthetic biology tools for targeted protein degradation [J].
Huang, Yu-En ;
Chen, Sijie ;
McCann, Meghan ;
Fan, Huaxun ;
Oh, Teak-Jung ;
Krishnamurthy, Vishnu ;
Bhurgri, Asher ;
Qiao, Huanyu ;
Yang, Jing ;
Zhang, Kai .
BIOPHYSICAL JOURNAL, 2025, 124 (03)
[48]   Targeted Protein Degradation: The New Frontier of Antimicrobial Discovery? [J].
Powell, Matthew ;
Blaskovich, Mark A. T. ;
Hansford, Karl A. .
ACS INFECTIOUS DISEASES, 2021, 7 (08) :2050-2067
[49]   Structural biology and drug discovery for protein-protein interactions [J].
Jubb, Harry ;
Higueruelo, Alicia P. ;
Winter, Anja ;
Blundell, Tom L. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) :241-248
[50]   Protein methyltransferases as a target class for drug discovery [J].
Robert A. Copeland ;
Michael E. Solomon ;
Victoria M. Richon .
Nature Reviews Drug Discovery, 2009, 8 :724-732